Investor Presentation via Investor Meet Company
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, will announce its unaudited interim results for the six months ended 30 June 2024 on 30 September 2024.
Christina Coughlin, MD, PhD, Avacta’s CEO, will discuss the results and the Company’s operational and clinical progress via the Investor Meet Company platform on 30 September 2024 at 11:00 BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 29 September 2024, 09:00 BST, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet AVACTA GROUP PLC via:
https://www.investormeetcompany.com/avacta-group-plc/register-investor.
Investors who already follow Avacta on the Investor Meet Company platform will automatically be invited.
The Company will also post its results presentation on its website at the following page: https://avacta.com/investors/documents-presentations.